|
1) 笹 征史. モノアミン神経伝達物質トランスポーター機能. 日本臨床. 2001; 59: 1457-64
|
|
|
|
2) Quaak M, van Schayck CP, Knaapen AM, et al. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases？ Eur Respir J. 2009; 33: 468-80
|
|
|
|
|
3) Olausson P, Engel JA, Soderpalm B. Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. Pharmacol Biochem Behav. 2002; 71: 757-71
|
|
|
|
|
|
4) Barnes PJ. Histamine and serotonin. Pulm Pharmacol Therapeut. 2001; 14: 329-39
|
|
|
|
|
|
5) Eddahibi S, Chaouat A, Morrell N, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation. 2003; 108: 1839-44
|
|
|
|
|
|
6) Eddahibi S, Hanoun N, Lanfumey L, et al. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest. 2000; 105: 1555-62
|
|
|
|
|
|
7) Willers ED, Newman JH, Loyd JE, et al. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006; 173: 798-802
|
|
|
|
|
|
8) Lechin F, van der Dijs B, Orozco B, et al. Increased levels of free serotonin in plasma of symptomatic asthmatic patients. Ann Allergy Asthma Immunol. 1996; 77: 245-53
|
|
|
|
|
|
9) Bayer H, Müller T, Myrtek D, et al. Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol. 2007; 36: 85-93
|
|
|
|
|
|
10) OMIM. http://www.ncbi.nlm.nih.gov/omim/182138
|
|
|
|
|
|
11) Hu X-Z, Lipsky RH, Zhu G, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006; 78: 815-26
|
|
|
|
|
|
12) Ishii T, Wakabayashi R, Kurosaki H, et al. Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms. J Hum Genet. 2011; 56: 41-6
|
|
|
|
|
|
13) Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet. 2010; 42: 36-44
|
|
|
|
|
|
14) Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA. 2009; 301: 2462-71
|
|
|
|
|
|
15) Maurer J, Rebbapragada V, Borson S, et al. ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134(4 Suppl): 43S-56S
|
|
|
|
|
|
16) Ulrich S, Hersberger M, Fischler M, et al. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease. Respiration. 2010; 79: 288-95
|
|
|
|
|
|
17) Fan VS, Ramsey SD, Giardino ND, et al. National Emphysema Treatment Trial (NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007; 167: 2345-53
|
|
|
|
|
|
18) Weitzenblum E, Hirth C, Ducolone A, et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981; 36: 752-8
|
|
|
|
|